228 related articles for article (PubMed ID: 37627183)
1. Understanding DNA Damage Response and DNA Repair in Multiple Myeloma.
Petrilla C; Galloway J; Kudalkar R; Ismael A; Cottini F
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627183
[TBL] [Abstract][Full Text] [Related]
2. Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.
Davalli P; Marverti G; Lauriola A; D'Arca D
Oxid Med Cell Longev; 2018; 2018():2389523. PubMed ID: 29770165
[TBL] [Abstract][Full Text] [Related]
3. Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic.
Priya B; Ravi S; Kirubakaran S
Drug Discov Today; 2023 Aug; 28(8):103662. PubMed ID: 37302542
[TBL] [Abstract][Full Text] [Related]
4. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
Banerjee S; Roy S
Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
[TBL] [Abstract][Full Text] [Related]
5. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.
Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM
Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185
[TBL] [Abstract][Full Text] [Related]
6. Are DNA damage response kinases a target for the differentiation treatment of acute myeloid leukemia?
Pennisi R; Albanesi J; Ascenzi P; Nervi C; di Masi A
IUBMB Life; 2018 Nov; 70(11):1057-1066. PubMed ID: 30296357
[TBL] [Abstract][Full Text] [Related]
7.
Warner E; Herberts C; Fu S; Yip S; Wong A; Wang G; Ritch E; Murtha AJ; Vandekerkhove G; Fonseca NM; Angeles A; Beigi A; Schönlau E; Beja K; Annala M; Khalaf D; Chi KN; Wyatt AW
Clin Cancer Res; 2021 Mar; 27(6):1650-1662. PubMed ID: 33414135
[TBL] [Abstract][Full Text] [Related]
8. Chlorin e6 mediated photodynamic therapy triggers resistance through ATM-related DNA damage response in lung cancer cells.
Ma QL; Shen MO; Han N; Xu HZ; Peng XC; Li QR; Yu TT; Li LG; Xu X; Liu B; Chen X; Wang MF; Li TF
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102645. PubMed ID: 34823034
[TBL] [Abstract][Full Text] [Related]
9. Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.
Gillardin PS; Descamps G; Maiga S; Tessoulin B; Djamai H; Lucani B; Chiron D; Moreau P; Le Gouill S; Amiot M; Pellat-Deceunynck C; Moreau-Aubry A
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295500
[TBL] [Abstract][Full Text] [Related]
10. DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.
Gourzones-Dmitriev C; Kassambara A; Sahota S; Rème T; Moreaux J; Bourquard P; Hose D; Pasero P; Constantinou A; Klein B
Cell Cycle; 2013 Sep; 12(17):2760-73. PubMed ID: 23966156
[TBL] [Abstract][Full Text] [Related]
11. The role of the DNA damage response kinase ataxia telangiectasia mutated in neuroprotection.
Marinoglou K
Yale J Biol Med; 2012 Dec; 85(4):469-80. PubMed ID: 23239948
[TBL] [Abstract][Full Text] [Related]
12. Germline Risk Contribution to Genomic Instability in Multiple Myeloma.
Janz S; Zhan F; Sun F; Cheng Y; Pisano M; Yang Y; Goldschmidt H; Hari P
Front Genet; 2019; 10():424. PubMed ID: 31139207
[TBL] [Abstract][Full Text] [Related]
13. DNA damage response pathways in tumor suppression and cancer treatment.
Liang Y; Lin SY; Brunicardi FC; Goss J; Li K
World J Surg; 2009 Apr; 33(4):661-6. PubMed ID: 19034564
[TBL] [Abstract][Full Text] [Related]
14. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase.
Song L; Lin C; Wu Z; Gong H; Zeng Y; Wu J; Li M; Li J
PLoS One; 2011; 6(9):e25454. PubMed ID: 21980462
[TBL] [Abstract][Full Text] [Related]
15. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
Sousa MM; Zub KA; Aas PA; Hanssen-Bauer A; Demirovic A; Sarno A; Tian E; Liabakk NB; Slupphaug G
PLoS One; 2013; 8(2):e55493. PubMed ID: 23405159
[TBL] [Abstract][Full Text] [Related]
16. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
[TBL] [Abstract][Full Text] [Related]
17. DNA damage response and hematological malignancy.
Takagi M
Int J Hematol; 2017 Sep; 106(3):345-356. PubMed ID: 28374143
[TBL] [Abstract][Full Text] [Related]
18. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
[TBL] [Abstract][Full Text] [Related]
19. 53BP1 is limiting for NHEJ repair in ATM-deficient model systems that are subjected to oncogenic stress or radiation.
Rybanska-Spaeder I; Reynolds TL; Chou J; Prakash M; Jefferson T; Huso DL; Desiderio S; Franco S
Mol Cancer Res; 2013 Oct; 11(10):1223-34. PubMed ID: 23858098
[TBL] [Abstract][Full Text] [Related]
20. Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells.
Jang SH; Lim JW; Morio T; Kim H
Free Radic Biol Med; 2012 Feb; 52(3):607-615. PubMed ID: 22178412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
